- Home
- Publications
- Publication Search
- Publication Details
Title
Gut microbiome in primary sclerosing cholangitis: A review
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 26, Issue 21, Pages 2768-2780
Publisher
Baishideng Publishing Group Inc.
Online
2020-06-05
DOI
10.3748/wjg.v26.i21.2768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways
- (2020) Mohammed Nabil Quraishi et al. Journal of Crohns & Colitis
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
- (2019) Nobuhiro Nakamoto et al. Nature Microbiology
- Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
- (2019) Brian M Fung et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
- (2019) Lijun Liao et al. GUT
- Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis
- (2019) Jessica R. Allegretti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
- (2019) Sara Lemoinne et al. GUT
- The gut microbial influence on cholestatic liver disease
- (2019) Martin Kummen et al. LIVER INTERNATIONAL
- Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
- (2019) Malte Rühlemann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
- (2019) Michael Huw Chapman et al. GUT
- Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2019) Ayesha Shah et al. SEMINARS IN LIVER DISEASE
- Pharmacologic management of primary sclerosing cholangitis: what’s in the pipeline?
- (2019) Jaspreet Suri et al. Expert Review of Gastroenterology & Hepatology
- Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
- (2019) Sara Vieira-Silva et al. Nature Microbiology
- Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease
- (2019) M. N. Quraishi et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption
- (2019) Yong-Dong Deng et al. Gut Pathogens
- Diversification of host bile acids by members of the gut microbiota
- (2019) Jenessa A. Winston et al. Gut Microbes
- Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN
- (2018) M. E. Joosse et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon
- (2018) Noa Krugliak Cleveland et al. Clinical Gastroenterology and Hepatology
- Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
- (2018) Amanda Ricciuto et al. Clinical Gastroenterology and Hepatology
- PC.01.8 THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
- (2018) N.F. Larusso et al. DIGESTIVE AND LIVER DISEASE
- Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor–Positive Cells and Pathogenesis of Cholestatic Liver Disease
- (2018) Dana Tedesco et al. GASTROENTEROLOGY
- Colesevelam attenuates cholestatic liver and bile duct injury inMdr2−/−mice by modulating composition, signalling and excretion of faecal bile acids
- (2018) Claudia Daniela Fuchs et al. GUT
- Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features
- (2018) Carolina Palmela et al. Gut and Liver
- Primary sclerosing cholangitis
- (2018) Jessica K Dyson et al. LANCET
- Urbanization and the gut microbiota in health and inflammatory bowel disease
- (2018) Tao Zuo et al. Nature Reviews Gastroenterology & Hepatology
- Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration
- (2018) Umang Jain et al. Cell Host & Microbe
- Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
- (2018) Amandeep K Dhillon et al. LIVER INTERNATIONAL
- Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells
- (2018) Franziska Mathies et al. JOURNAL OF IMMUNOLOGY
- Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
- (2017) Tobias J. Weismüller et al. GASTROENTEROLOGY
- Fungal dysbiosis in cirrhosis
- (2017) Jasmohan S Bajaj et al. GUT
- The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
- (2017) Mark R. Deneau et al. HEPATOLOGY
- Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis
- (2017) David N. Assis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Genetics of primary sclerosing cholangitis and pathophysiological implications
- (2017) Xiaojun Jiang et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiota and IBD: causation or correlation?
- (2017) Josephine Ni et al. Nature Reviews Gastroenterology & Hepatology
- Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
- (2017) Lukas Bajer et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease
- (2017) J Torres et al. United European Gastroenterology Journal
- The features of mucosa-associated microbiota in primary sclerosing cholangitis
- (2016) J. Torres et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
- (2016) Long-Xian Lv et al. ENVIRONMENTAL MICROBIOLOGY
- Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
- (2016) Aida Kapic Lunder et al. GASTROENTEROLOGY
- Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis
- (2016) Malte Christoph Rühlemann et al. GUT
- The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
- (2016) Mohammed Nabil Quraishi et al. GUT
- Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis
- (2016) Kentaro Iwasawa et al. GUT
- Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
- (2016) João Sabino et al. GUT
- The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
- (2016) Martin Kummen et al. GUT
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
- (2015) James H. Tabibian et al. HEPATOLOGY
- Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
- (2015) D. Kevans et al. Journal of Crohns & Colitis
- Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study
- (2015) Peter De Cruz et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
- (2014) Phillip L. Molyneaux et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
- (2014) Dirk Gevers et al. Cell Host & Microbe
- The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
- (2014) Noortje G. Rossen et al. Journal of Crohns & Colitis
- G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
- (2014) Klemens Högenauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- Mortality in inflammatory bowel disease patients under 65 years of age
- (2014) Aoibhlinn O'Toole et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in utah children: Epidemiology and natural history
- (2013) Mark Deneau et al. HEPATOLOGY
- Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis
- (2013) Janosch Katt et al. HEPATOLOGY
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- Isolation and characterization of a bile acid inducible 7α-dehydroxylating operon in Clostridium hylemonae TN271
- (2009) Jason M. Ridlon et al. ANAEROBE
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome
- (2008) B. V. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation